Anti-MLLT10 monoclonal antibody

Pre-made anti-MLLT10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MLLT10/MLLT10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1196-Ab-1/ GM-Tg-hg-IP1196-Ab-2Anti-Human MLLT10 monoclonal antibodyHuman
GM-Tg-rg-IP1196-Ab-1/ GM-Tg-rg-IP1196-Ab-2Anti-Rat MLLT10 monoclonal antibodyRat
GM-Tg-mg-IP1196-Ab-1/ GM-Tg-mg-IP1196-Ab-2Anti-Mouse MLLT10 monoclonal antibodyMouse
GM-Tg-cynog-IP1196-Ab-1/ GM-Tg-cynog-IP1196-Ab-2Anti-Cynomolgus/ Rhesus macaque MLLT10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1196-Ab-1/ GM-Tg-felg-IP1196-Ab-2Anti-Feline MLLT10 monoclonal antibodyFeline
GM-Tg-cang-IP1196-Ab-1/ GM-Tg-cang-IP1196-Ab-2Anti-Canine MLLT10 monoclonal antibodyCanine
GM-Tg-bovg-IP1196-Ab-1/ GM-Tg-bovg-IP1196-Ab-2Anti-Bovine MLLT10 monoclonal antibodyBovine
GM-Tg-equg-IP1196-Ab-1/ GM-Tg-equg-IP1196-Ab-2Anti-Equine MLLT10 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1196-Ab-1/ GM-Tg-hg-IP1196-Ab-2; GM-Tg-rg-IP1196-Ab-1/ GM-Tg-rg-IP1196-Ab-2;
GM-Tg-mg-IP1196-Ab-1/ GM-Tg-mg-IP1196-Ab-2; GM-Tg-cynog-IP1196-Ab-1/ GM-Tg-cynog-IP1196-Ab-2;
GM-Tg-felg-IP1196-Ab-1/ GM-Tg-felg-IP1196-Ab-2; GM-Tg-cang-IP1196-Ab-1/ GM-Tg-cang-IP1196-Ab-2;
GM-Tg-bovg-IP1196-Ab-1/ GM-Tg-bovg-IP1196-Ab-2; GM-Tg-equg-IP1196-Ab-1/ GM-Tg-equg-IP1196-Ab-2
Products NameAnti-MLLT10 monoclonal antibody
Formatmab
Target NameMLLT10
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MLLT10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1196-Ag-1Recombinant multi-species AF10/ MLLT10 protein


    Target information

    Target IDGM-IP1196
    Target NameMLLT10
    Gene ID8028,17354,361285,487096,101095180,519864,100067409
    Gene Symbol and SynonymsAF10,B130021D15Rik,D630001B22Rik,mKIAA4140,MLLT10
    Uniprot AccessionP55197
    Uniprot Entry NameAF10_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000078403
    Target ClassificationTumor-associated antigen (TAA)

    The target: MLLT10, gene name: MLLT10, also named as AF10. This gene encodes a transcription factor and has been identified as a partner gene involved in several chromosomal rearrangements resulting in various leukemias. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.